446 related articles for article (PubMed ID: 32486355)
21. Temporal trends of nonalcoholic fatty liver disease-related hepatocellular carcinoma in the veteran affairs population.
Mittal S; Sada YH; El-Serag HB; Kanwal F; Duan Z; Temple S; May SB; Kramer JR; Richardson PA; Davila JA
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):594-601.e1. PubMed ID: 25148760
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology of non-alcoholic fatty liver disease-related hepatocellular carcinoma and its implications.
Wong SW; Ting YW; Chan WK
JGH Open; 2018 Oct; 2(5):235-241. PubMed ID: 30483595
[TBL] [Abstract][Full Text] [Related]
23. The Growing Landscape of NAFLD-Associated Hepatocellular Carcinoma and Its Impact in Surveillance.
Machado MV
GE Port J Gastroenterol; 2024 Feb; 31(1):14-23. PubMed ID: 38314031
[TBL] [Abstract][Full Text] [Related]
24. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.
Baffy G; Brunt EM; Caldwell SH
J Hepatol; 2012 Jun; 56(6):1384-91. PubMed ID: 22326465
[TBL] [Abstract][Full Text] [Related]
25. Hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis.
Tovo CV; de Mattos AZ; Coral GP; Sartori GDP; Nogueira LV; Both GT; Villela-Nogueira CA; de Mattos AA
World J Gastroenterol; 2023 Jan; 29(2):343-356. PubMed ID: 36687125
[TBL] [Abstract][Full Text] [Related]
26. Exploring Opportunities to Enhance the Screening and Surveillance of Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease (NAFLD) through Risk Stratification Algorithms Incorporating Ultrasound Elastography.
Taru MG; Lupsor-Platon M
Cancers (Basel); 2023 Aug; 15(16):. PubMed ID: 37627125
[TBL] [Abstract][Full Text] [Related]
27. Nonalcoholic Fatty Liver Disease-Related Hepatocellular Carcinoma: A Problem of Growing Magnitude.
Pocha C; Kolly P; Dufour JF
Semin Liver Dis; 2015 Aug; 35(3):304-17. PubMed ID: 26378646
[TBL] [Abstract][Full Text] [Related]
28. NAFLD and NAFLD-related HCC in Asia: Burden and Surveillance.
Koh JH; Wang M; Suzuki H; Muthiah M; Ng CH; Huang DQ
J Clin Exp Hepatol; 2024; 14(1):101213. PubMed ID: 38076360
[TBL] [Abstract][Full Text] [Related]
29. Characterization of hepatocellular carcinoma (HCC) in non-alcoholic fatty liver disease (NAFLD) patients without cirrhosis.
Mohamad B; Shah V; Onyshchenko M; Elshamy M; Aucejo F; Lopez R; Hanouneh IA; Alhaddad R; Alkhouri N
Hepatol Int; 2016 Jul; 10(4):632-9. PubMed ID: 26558795
[TBL] [Abstract][Full Text] [Related]
30. AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease.
Beale G; Chattopadhyay D; Gray J; Stewart S; Hudson M; Day C; Trerotoli P; Giannelli G; Manas D; Reeves H
BMC Cancer; 2008 Jul; 8():200. PubMed ID: 18638391
[TBL] [Abstract][Full Text] [Related]
31. Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes.
Ito T; Nguyen MH
J Hepatocell Carcinoma; 2023; 10():413-428. PubMed ID: 36926055
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular Carcinoma in Non-Alcoholic Fatty Liver Disease: From Epidemiology to Diagnostic Approach.
Grgurevic I; Bozin T; Mikus M; Kukla M; O'Beirne J
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830997
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?
Fassio E; Barreyro FJ; Pérez MS; Dávila D; Landeira G; Gualano G; Ruffillo G
World J Hepatol; 2022 Feb; 14(2):354-371. PubMed ID: 35317172
[TBL] [Abstract][Full Text] [Related]
34. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.
Thompson Coon J; Rogers G; Hewson P; Wright D; Anderson R; Cramp M; Jackson S; Ryder S; Price A; Stein K
Health Technol Assess; 2007 Sep; 11(34):1-206. PubMed ID: 17767898
[TBL] [Abstract][Full Text] [Related]
35. Asian perspective on NAFLD-associated HCC.
Yip TC; Lee HW; Chan WK; Wong GL; Wong VW
J Hepatol; 2022 Mar; 76(3):726-734. PubMed ID: 34619251
[TBL] [Abstract][Full Text] [Related]
36. A Practical Guideline for Hepatocellular Carcinoma Screening in Patients at Risk.
Frenette CT; Isaacson AJ; Bargellini I; Saab S; Singal AG
Mayo Clin Proc Innov Qual Outcomes; 2019 Sep; 3(3):302-310. PubMed ID: 31485568
[TBL] [Abstract][Full Text] [Related]
37. Profile of patients with hepatocellular carcinoma: An experience from a tertiary care center in India.
Musunuri B; Shetty S; Bhat G; Udupa K; Pai A
Indian J Gastroenterol; 2022 Apr; 41(2):127-134. PubMed ID: 35226292
[TBL] [Abstract][Full Text] [Related]
38. Changes in Characteristics of Patients with Liver Cirrhosis Visiting a Tertiary Hospital over 15 Years: a Retrospective Multi-Center Study in Korea.
Jang WY; Chung WJ; Jang BK; Hwang JS; Lee HJ; Hwang MJ; Kweon YO; Tak WY; Park SY; Lee SH; Lee CH; Kim BS; Kim SH; Suh JI; Park JG
J Korean Med Sci; 2020 Jul; 35(29):e233. PubMed ID: 32715667
[TBL] [Abstract][Full Text] [Related]
39. Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets.
Chen Y; Wang W; Morgan MP; Robson T; Annett S
Front Endocrinol (Lausanne); 2023; 14():1148934. PubMed ID: 37361533
[TBL] [Abstract][Full Text] [Related]
40. The epidemiology of non-alcoholic fatty liver disease.
Bellentani S
Liver Int; 2017 Jan; 37 Suppl 1():81-84. PubMed ID: 28052624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
